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Demand for Dental Care Services
Global awareness of growing demand for oral health care services became prominent over past
several decades (1). Far reaching consequences of clinical dentistry for overall societal welfare were
more obvious to the governing health authorities in mature market economies at first (2). Eastern
European and Balkan health systems suffered from serious development setbacks during painful
transitional health reforms taking place in the region since 1989 (3). Some of the core challenges
across the region were temporary worsened insurance coverage in most countries of the region and
huge contribution of out-of-pocket payments by ordinary citizens (4). As in somany areas of curative
medicine, dental care was undergoing the same evolution. The early stages of this process were quite
challenging for the regional health sector, and successful adaptation to the increasingly globalized
health care market took many years to happen (5). Peculiarity of dental medicine is reflected in
strong demand for frequent services, initiated by common acute disorders and adverse consequences
of treatment procedures (6). Preventive and conservative dentistry in pediatric populations has
significant long-term impact to the dental expenditure across the region (7). In some other areas,
such as restorative dentistry, these issues are particularly prominent (8). In many transitional health
systems, financial constraints worsened by global economic recession reflected heavily on dental
care, imposing further narrowing of existing reimbursement practices as it happened in Bulgaria (9).
The Case of Serbia
Serbia, as the largest successor state of former Yugoslavia, has its health system legacy in many
ways different from Post-Semashko systems of other South East European countries (10). It is
funded through one core state-owned health insurance fund (11) whose revenuesmostly come from
mandatory taxation of employers and employees (12). This transitional health system is currently
undergoing significant reform from massive, hospital-based, supply-oriented one toward more
responsive, lighter primary care-oriented system (13). Regardless of many successes, substantial
challenges remain and these are reflected in evolving structure of national health care spending over
past two decades (14). As in most of remaining European nations, work load to the entire health
system and expenditures are dominated by accelerated population aging (15, 16) and prosperity
diseases (17). So far, there are diverse difficulties related to inefficient funding mechanisms (18) and
poor access and affordability of medical care (19) to the vast population of poor citizens and those
residing in rural areas (20). Dental services remain seriously underfunded from public resources
and this issue shapes the related to oral health of the nation (21). There are very few published local
estimates on budget impact of clinical dentistry in theBalkans and related cost-of-illness studies.One
of the few promising signs of growing awareness among policy makers is prioritizing oral health in
some long-term national public health strategies (22).
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FIGURE 1 | Value-based turnover of publicly financed consumption of dental medicines presented across ground ATC medicines classes according
to 2004–2013 growth in value-based turnover.
Public Spending for Dental Care and
Medicines Over the Last Decade
Since 2004, National Agency for Medicines and Medical Devices
of Serbia (ALIMS) issue commercially available periodic reports
on precise structure of prescription dispensing and value of sales
of all pharmaceuticals within the publicly funded health care
facilities, pharmacies, and wholesalers. Recent research of trends
over past decade has shown bold growth in local market size (23)
dominated by biologicals (24) and oncology-related treatment
options (25). These same sources offer us best attainable insight
into the structure of Serbian market of dental medicines classified
within broadly recognized Anatomical–Technological–Chemical
classification system (ATC). Data presented in Figure 1 point out
the falling prescription and dispensing of “Caries prophylactic
agents” (A01AA code) whose value-based turnover decreased
fromAC66,704 in 2004 toAC21,397 in 2013 (actual peak value in the
observed period was AC 238,397 back in 2010). At the same time,
sales of “Other agents for local oral treatment” (A01AD code)
grew eightfold from AC 302,608 in 2004 to AC 2,413,302 in 2013
(actual peak value in the observed period wasAC 3,079,162 back in
2011). Slightly slower increase but the one dominating the market
was the one of “Anti-infectives and antiseptics for local oral treat-
ment” (A01AB code) rising fromAC917,894 in 2004 toAC2,736,887
in 2013 (actual peak value in the observed period wasAC 3,833,995
back in 2008). Combined market size of all these three major
groups of drugs used in various branches of dental medicine grew
from AC 1,287,207 in 2004 to AC 5,171,585 in 2013. It is important
to emphasize that entire national consumption of stomatological
preparations actually contracted due to global economic recession
and value of spending was exceeding AC 6,000,000 back in 2010.
The strong impact of economic crisis on Balkan pharmaceutical
markets was noticed across the region with surprisingly better
performance of transitional economies compared to OECD ones
(26). Size of targeted public spending for oral health inclusive
of capital investment, staff salaries, utilities, consumables, and
other costs by far exceeds drug acquisition costs. According to the
first officially available data, Republican Health Insurance Fund
of Serbia (RFZO) has devoted AC 51,131,383 in 2007 while over
21% less only 7 years after in 2013 (AC 40,351,340). Referring to the
entire public health spending in the country funded by RFZO that
this effectively meant percentage point decrease of governmental
resources assigned for oral health programs from 2.82% in 2007
to 2.12% in 2013. These facts make de-investment into the clinical
dentistry a rare exception compared to the many areas or clinical
medicine regardless of crisis induced budget constraint (27). Such
reimbursement policy imposed by local authorities effectively
shifted financial burden of primary dentistry care to the ordinary
citizens. Government legislature confirms that mandatory health
insurance premiums were not inclusive of adult dentistry care
unless in case of emergencies (28). Unlike among high-income
EU economies, such policy in Serbia led to strong fall of demand
for dental services motivated by simple lack of affordability rather
than clinical need (29). Bureaucratic obstacles to the provision of
dentist services contributed to the aforementioned phenomenon
as well. Poor access to these medical services ultimately exposed
well-known boomerang effect. Patients who were denied right
to treatment in the early stages of their illness much later must
be treated for severe form of neglected illness, which is much
more expensive to treat. Outcomes of such delayed care are much
less favorable and predictable and these interventions lose their
cost-effectiveness when applied in clinically advanced cases (30).
Core Future Challenges of Dental Services
Provision and Financing
Dental medicine is one of the rare examples of flourishing of
private-owned clinical facilities rising from historical legacy of
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state-owned health care in the region. Nevertheless, due to several
core weaknesses, pace of contemporary Serbian oral health efforts
seems to be insufficient to cover long-term population needs. Sur-
prisingly, strong development of pharmaceutical market in other
areas of clinical medicine occasionally reaches several fold annual
growth. Due to public funding limitations, such setting creates
significant pressures against financing of dental services. Accumu-
lated public debt toward multinational industries of pharmaceuti-
cals and medicinal devices will most likely continue to grow fur-
ther (31). Some of the possible escape strategies should be rooted
in evidence-based resource allocation policies. Regional efforts
to establish feasible local health technology assessment agencies
might be very rewarding in the long run. Throughout most of
WesternBalkans, cost-effectiveness estimates are not evenmanda-
tory condition for marketing approval of novel medicines. The
core challenge lying ahead of more effective dental care provision
in Serbia remains lack of insurance coverage and too high out-of-
pocket payments by citizens. Bold growth of out-of-pocket health
care spending is unfortunately evident in most globally leading
emerging markets, which severely affects affordability of medical
care to the poor (32). Demand for dentist’s services remains much
higher than in most other clinical disciplines. Serbia’s dental
healthcare market will probably achieve further growth in the
upcoming years but mostly within its already conceived private
sector. Decreasing public expenditure on oral health poses an
unpleasant setback, which might be corrected after consolidation
of economic growth (33). If national authorities commit them-
selves to prioritizing preventive dentistry (34), such move could
yield significant gains (35). Unpredictable financial sustainability
of existing health insurance systems in the Balkans will demand
long-term efforts targeted to achieve accessible dental care for
local communities in future.
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